Clinical Trial Update: CRRS-4 Pivotal Somo•v™ ABUS ROC Reader Observer Study

View source ↗

Summary

An update on the CRRS-4 pivotal Somo•v ABUS ROC Reader Observer Study for breast cancer, with the study status shown as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Somo•v ABUS ROC Reader

Snippet

Sponsor: U-Systems, Inc. | Conditions: Breast Cancer | Status: COMPLETED